title: Neoatherosclerosis From a Pathologist's Point of View.
authors.affiliation: From the CVPath Institute, Gaithersburg, MD.
authors.forename: Maria E
authors.initials: ME
authors.lastname: Romero
authors.affiliation: From the CVPath Institute, Gaithersburg, MD.
authors.forename: Kazuyuki
authors.initials: K
authors.lastname: Yahagi
authors.affiliation: From the CVPath Institute, Gaithersburg, MD.
authors.forename: Frank D
authors.initials: FD
authors.lastname: Kolodgie
authors.affiliation: From the CVPath Institute, Gaithersburg, MD. rvirmani@cvpath.org.
authors.forename: Renu
authors.initials: R
authors.lastname: Virmani
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects* / Q000295:instrumentation; D017023:Coronary Angiography / Q000379:methods; D003324:Coronary Artery Disease / Q000000981:diagnostic imaging / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D054855:Drug-Eluting Stents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D058426:Neointima / Q000473:pathology* / Q000503:physiopathology; D011379:Prognosis; D011475:Prosthesis Failure; D018570:Risk Assessment; D012720:Severity of Illness Index; D016019:Survival Analysis
keywords: atherosclerosis; drug-eluting stents; paclitaxel; pathology; stents